Literature DB >> 25512019

Dietary supplementation with omega-3 polyunsaturated fatty acids modulate matrix metalloproteinase immunoreactivity in a mouse model of pre-abdominal aortic aneurysm.

Kristyn Kavazos1, Maria Nataatmadja2, Kathryn M Wales1, Elke Hartland1, Chloe Williams1, Fraser D Russell3.   

Abstract

BACKGROUND: Two-day infusion of angiotensin II to apolipoprotein E-deficient (ApoE(-/-)) mice provides a model of pre-abdominal aortic aneurysm. Long chain omega-3 polyunsaturated fatty acids (n-3 PUFAs) have anti-inflammatory effects. This study examined the effect of an eight-week low or high n-3 PUFA diet in ApoE(-/-) mice on matrix metalloproteinase (MMP) expression and elastin degradation.
METHODS: ApoE(-/-) mice were fed a low or high n-3 PUFA diet for eight weeks prior to two-day infusion with angiotensin II. The omega-3 index, MMP-2, MMP-9, TIMP-1, and TGF-β1 immunoreactivity, and elastin fragmentation were measured.
RESULTS: The omega-3 index with the low and high n-3 PUFA diet was 3.78% and 13.03%, respectively. MMP-9 immunoreactive stain intensity was lower in mice fed the high, compared to the low n-3 PUFA diet in endothelial cells (suprarenal aorta), and inflammatory cells (suprarenal and infrarenal aorta). Inflammatory cells had higher TIMP-1 and TGF-β1 stain intensity in mice fed the high, compared to the low n-3 PUFA diet (suprarenal aorta). MMP-2 immunoreactivity was unaffected by diet. A non-significant trend for reduced elastin fragmentation was observed in mice fed the high n-3 PUFA diet.
CONCLUSION: Dietary supplementation with n-3 PUFAs may have protective anti-inflammatory effects mediated through modulation of MMPs and TIMPs.
Copyright © 2014 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Abdominal aortic aneurysm; Cytokines; Elastin; Long chain omega-3 polyunsaturated fatty acids; Matrix metalloproteinases; Transforming growth factor-β1

Mesh:

Substances:

Year:  2014        PMID: 25512019     DOI: 10.1016/j.hlc.2014.11.005

Source DB:  PubMed          Journal:  Heart Lung Circ        ISSN: 1443-9506            Impact factor:   2.975


  6 in total

1.  n-3 PUFAs improve erythrocyte fatty acid profile in patients with small AAA: a randomized controlled trial.

Authors:  Lara T Meital; Mark T Windsor; Rebecca M L Ramirez Jewell; Peter Young; Karl Schulze; Rebecca Magee; Jill O'Donnell; Pankaj Jha; Maria Perissiou; Jonathan Golledge; Tom G Bailey; Peter Brooks; Christopher D Askew; Fraser D Russell
Journal:  J Lipid Res       Date:  2019-03-26       Impact factor: 5.922

2.  D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.

Authors:  Nicolas H Pope; Morgan Salmon; John P Davis; Anuran Chatterjee; Gang Su; Michael S Conte; Gorav Ailawadi; Gilbert R Upchurch
Journal:  FASEB J       Date:  2016-09-12       Impact factor: 5.191

3.  The Effect of n-3 PUFA on the Development of Abdominal Aortic Aneurysm.

Authors:  Nobuhiro Zaima
Journal:  J Atheroscler Thromb       Date:  2017-05-26       Impact factor: 4.928

4.  Disparate biomechanical properties of the aorta in non-aneurysmal and aneurysmal mice treated with angiotensin II.

Authors:  Sofie De Moudt; Jhana O Hendrickx; Guido R Y De Meyer; Wim Martinet; Paul Fransen
Journal:  Physiol Rep       Date:  2022-09

Review 5.  Dietary therapy in abdominal aortic aneurysm - Insights from clinical and experimental studies.

Authors:  Li Yin; Alexander Christopher Gregg; Alessandra Marie Riccio; Nicholas Hoyt; Zain Hussain Islam; Jungeun Ahn; Quang Le; Paranjay Patel; Mengxue Zhang; Xinran He; Matthew McKinney; Eric Kent; Bowen Wang
Journal:  Front Cardiovasc Med       Date:  2022-09-21

6.  Arachidonic Acid, but Not Omega-3 Index, Relates to the Prevalence and Progression of Abdominal Aortic Aneurysm in a Population-Based Study of Danish Men.

Authors:  Jes S Lindholt; Katrine L Kristensen; Elena Burillo; Diego Martinez-Lopez; Carlos Calvo; Emilio Ros; Jose L Martín-Ventura; Aleix Sala-Vila
Journal:  J Am Heart Assoc       Date:  2018-01-26       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.